TrialLeukemia2003

No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.

R Hast et al.PubMed ↗Publisher ↗

No numbers read from the abstract.